skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Academic Search Premier remover assunto: Hematology remover Adult remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Genetic aberrations and survival in plasma cell leukemia
Genetic aberrations and survival in plasma cell leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic aberrations and survival in plasma cell leukemia

TIEDEMANN, R. E ; GONZALEZ-PAZ, N ; GREIPP, P. R ; DISPENZIERI, A ; LACY, M. Q ; RAJKUMAR, S. V ; BERGSAGEL, P. L ; STEWART, A. K ; FONSECA, R ; KYLE, R. A ; SANTANA-DAVILA, R ; PRICE-TROSKA, T ; VAN WIER, S. A ; CHNG, W. J ; KETTERLING, R. P ; GERTZ, M. A ; HENDERSON, K

Leukemia, 2008-05, Vol.22 (5), p.1044-1052 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
2
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

Avet-Loiseau, H ; Durie, B G M ; Cavo, M ; Attal, M ; Gutierrez, N ; Haessler, J ; Goldschmidt, H ; Hajek, R ; Lee, J H ; Sezer, O ; Barlogie, B ; Crowley, J ; Fonseca, R ; Testoni, N ; Ross, F ; Rajkumar, S V ; Sonneveld, P ; Lahuerta, J ; Moreau, P ; Morgan, G

Leukemia, 2013-03, Vol.27 (3), p.711-717 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Thalidomide as initial therapy for early-stage myeloma
Thalidomide as initial therapy for early-stage myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thalidomide as initial therapy for early-stage myeloma

RAJKUMAR, S. V ; GERTZ, M. A ; GREIPP, P. R ; WITZIG, T. E ; LACY, M. Q ; DISPENZIERI, A ; FONSECA, R ; GEYER, S. M ; ITURRIA, N ; KUMAR, S ; LUST, J. A ; KYLE, R. A

Leukemia, 2003-04, Vol.17 (4), p.775-779 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
4
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

KUMAR, S ; DISPENZIERI, A ; GERTZ, M. A ; LACY, M. Q ; HAYMAN, S. R ; BUADI, F. K ; GASTINEAU, D. A ; LITZOW, M. R ; FONSECA, R ; ROY, V ; RAJKUMAR, S. V

Leukemia, 2007-09, Vol.21 (9), p.2035-2042 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
5
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S ; Mikhael, J R ; LaPlant, B R ; Laumann, K M ; Kumar, S ; Roy, V ; Dingli, D ; Bergsagel, P L ; Buadi, F K ; Rajkumar, S V ; Fonseca, R ; Gertz, M A ; Kapoor, P ; Sher, T ; Hayman, S R ; Stewart, A K ; Dispenzieri, A ; Kyle, R A ; Gonsalves, W I ; Reeder, C B ; Lin, Y ; Go, R S ; Leung, N ; Kourelis, T ; Lust, J A ; Russell, S J ; Chanan-Khan, A A ; Lacy, M Q

Leukemia, 2018-03, Vol.32 (3), p.719-728 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome

Barrio, S ; Shanafelt, T D ; Ojha, J ; Chaffee, K G ; Secreto, C ; Kortüm, K M ; Pathangey, S ; Van-Dyke, D L ; Slager, S L ; Fonseca, R ; Kay, N E ; Braggio, E

Leukemia, 2017-01, Vol.31 (1), p.170-176 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

LACY, M. Q ; HAYMAN, S. R ; ZELDENRUST, S ; FONSECA, R ; BERGSAGEL, P. L ; ROY, V ; MIKHAEL, J. R ; STEWART, A. K ; LAUMANN, K ; ALLRED, J. B ; MANDREKAR, S. J ; RAJKUMAR, S. V ; GERTZ, M. A ; BUADI, F ; SHORT, K. D ; DISPENZIERI, A ; KUMAR, S ; GREIPP, P. R ; LUST, J. A ; RUSSELL, S. J ; DINGLI, D

Leukemia, 2010-11, Vol.24 (11), p.1934-1939 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

KUMAR, S ; LACY, M. Q ; KYLE, R. A ; LITZOW, M. R ; GERTZ, M. A ; DISPENZIERI, A ; RAJKUMAR, S. V ; FONSECA, R ; GEYER, S ; ALLMER, C ; WITZIG, T. E ; LUST, J. A ; GREIPP, P. R

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (2), p.161-167 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts
Material Type:
Artigo 		Adicionar ao Meu Espaço

High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

HOEGH-PETERSEN, M ; GOODYEAR, D ; STEWART, D ; RUSSELL, J. A ; STOREK, J ; GEDDES, M. N ; LIU, S ; UGARTE-TORRES, A ; LIU, Y ; WALKER, J. T ; FONSECA, K ; DALY, A ; DUGGAN, P

Bone marrow transplantation (Basingstoke), 2011-08, Vol.46 (8), p.1104-1112 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy

KUMAR, S ; GERTZ, M. A ; RAJKUMAR, S. V ; DISPENZIERI, A ; LACY, M. Q ; WELLIK, L. A ; FONSECA, R ; LUST, J. A ; WITZIG, T. E ; KYLE, R. A ; GREIPP, P. R

Bone marrow transplantation (Basingstoke), 2004-08, Vol.34 (3), p.235-239 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2001  (4)
  2. 2001Até2003  (4)
  3. 2004Até2006  (5)
  4. 2007Até2010  (3)
  5. Após 2010  (5)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.